Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis-Reference-Cited by-同舟云学术

Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis

Published:2015-01-06 Issue:11 Volume:45 Page:1062-1070
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Akiyama Shintaro¹,Ikeda Kenji¹²,Sezaki Hitomi¹²,Fukushima Taito¹²,Sorin Yushi¹²,Kawamura Yusuke¹²,Saitoh Satoshi¹²,Hosaka Tetsuya¹²,Akuta Norio¹²,Kobayashi Masahiro¹²,Suzuki Fumitaka¹²,Suzuki Yoshiyuki¹²,Arase Yasuji¹²,Kumada Hiromitsu¹²

Affiliation:

1. Department of Hepatology; Toranomon Hospital; Tokyo Japan

2. Okinaka Memorial Institute for Medical Research; Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12455/fullpdf

Reference16 articles.

1. Compensated cirrhosis: natural history and prognostic factors;Gines;Hepatology,1987

2. EASL clinical practice guideline on the management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis;European Association for the Study of the Liver;J Hepatol,2010